Aclinical team in Boston has reported being able to monitor a COVID-19 patient remotely, thanks to a device developed at CSAIL that can monitor a patient’s breathing, movement and sleep patterns using wireless signals.

A team led by MIT researchers and including experts from many institutions is developing a system that augments “manual” contact tracing by public health officials, while preserving the privacy of all individuals.

A company, founded by Marilyn Matz SM ’80 and CSAIL's Michael Stonebraker, helps pharmaceutical companies, research institutes, and biotech companies turn data into insights.

Love is Blind's AI/data scientist Cameron Hamilton speaks with CSAIL's Rachel Gordon on his role as an AI/data scientist, finding love on the hugely popular Netflix show, and where he sees the future of digital dating.

With much of the U.S. in shutdown mode to limit the spread of the Covid-19 disease, a debate has sprung up about when the country might “reopen” commerce, to limit economic fallout from the pandemic. But as a new study co-authored by an MIT economist shows, taking care of public health first is precisely what generates a stronger economic rebound later.

Michael Z. Lin, Associate Professor, Stanford University, describes the basic biology of coronaviruses and the disease COVID-19, projections for the current epidemic, and reviews medications currently in clinical trials.

According to MIT CSAIL's Dr. Amar Gupta, whose work concentrates on telemedicine, there are currently many barriers to making health care better, safer, and more affordable for everyone, despite government claims that electronic health records would revolutionize the system.

As more Covid-19 cases appear in the United States and around the world, the need for fast, easy-to-use diagnostic tests is becoming ever more pressing. A startup company spun out from MIT is now working on a paper-based test that can deliver results in under half an hour, based on technology developed at MIT’s Institute for Medical Engineering and Science (IMES).